Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sajjad Afraz"'
Autor:
Jason Chung, Owais Mian, Ivan Stevic, Sajjad Afraz, Anthony Chan, Howard Chan, Bret M. Evers, Davide Matino
Publikováno v:
Thrombosis Update, Vol 14, Iss , Pp 100163- (2024)
Externí odkaz:
https://doaj.org/article/5c3e90eaeebb4a75bcaeb3f8a55b722e
Autor:
Sajjad Afraz, Ivan Stevic, Davide Matino, Jianping Wen, Helen Atkinson, Anthony K. C. Chan, Gonzalo Hortelano
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Hemophilia A is an X-linked recessive congenital bleeding disorder. Exogenous infusion of FVIII is the treatment of choice, and the development of immunoglobulins against FVIII (inhibitors) remains the major challenge in clinical management
Externí odkaz:
https://doaj.org/article/aaff11cce0044619b9201f7d45a36d30
Publikováno v:
Thrombosis Update, Vol 11, Iss , Pp 100133- (2023)
Background: Plasma D-Dimer (DD) is a degradation product of cross-linked fibrin and represents the activation of the fibrinolytic and coagulation system. Clinically, DD tests have a high negative prediction value for thrombotic events and can be used
Externí odkaz:
https://doaj.org/article/39686a2a51ce4160b536bb2ca6e54dae
Autor:
Davide Matino, Sajjad Afraz, George Zhao, Paul Tieu, Marco Gargaro, Francesca Fallarino, Alfonso Iorio
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The occurrence of neutralizing anti-FVIII antibodies is a major complication in the treatment of patients affected by hemophilia A. The immune response to FVIII is a complex, multi-factorial process that has been extensively studied for the past two
Externí odkaz:
https://doaj.org/article/0427c51ab97b4eaf9ea594c1723c42f7
Publikováno v:
Blood. 140:11289-11290
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::430b6789d08d3914763ff0075f52e4d7
https://doi.org/10.1182/blood-2022-170716
https://doi.org/10.1182/blood-2022-170716
Autor:
Allen Green, Yu-Min P. Shen, Andrew T. Nelson, Ravi Sarode, Ibrahim F. Ibrahim, Jing Cao, Sajjad Afraz, Sean G. Yates
Publikováno v:
Annals of hematologyReferences. 101(12)
Acquired von Willebrand syndrome (AVWS) is a rare hematologic disorder characterized by quantitative or qualitative defects of von Willebrand factor (vWF), a protein crucial for normal hemostasis. AVWS has been described in association with several p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa6096b682a02d4f5def0e6570d792bb
https://pubmed.ncbi.nlm.nih.gov/36194257
https://pubmed.ncbi.nlm.nih.gov/36194257
Autor:
Ibrahim Yusuf, Michael H. Lee, Jason Chung, Ha H. Nguyen, Paul Tieu, Tushar Dhawan, Shawn Khan, Sophie Shu-Hsuan Liu, Sajjad Afraz
Publikováno v:
Journal of Translational Genetics and Genomics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4b9a647103c04e358fd88f442f70af3
https://doi.org/10.20517/jtgg.2020.18
https://doi.org/10.20517/jtgg.2020.18
Publikováno v:
Blood. 134:2402-2402
Background: Management of hemophilia A with exogenous factor VIII (FVIII) infusions can result in the development of alloantibodies that neutralize FVIII activity (inhibitors). The presence of FVIII inhibitors is associated with high morbidity and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e14e35db19312755e6d28e79388f8131
https://doi.org/10.1182/blood-2019-131441
https://doi.org/10.1182/blood-2019-131441
Publikováno v:
Journal of Surgical Research. 176:696-700
Background Pioglitazone, a thiazolidinedione, is primarily used as an antidiabetic agent. In addition, recent reports have identified anti-ischemic and anti-inflammatory properties of pioglitazone through nitric oxide (NO) pathways. Objective To dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f48097591cde26317b3c1b2c4e27771
https://doi.org/10.1016/j.jss.2011.10.013
https://doi.org/10.1016/j.jss.2011.10.013